Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Blood biomarker that predicts persistent cognitive dysfunction after concussion

Blood biomarker that predicts persistent cognitive dysfunction after concussion

US Patent 11761959 · Granted Sep 19, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Blood biomarker that predicts persistent cognitive dysfunction after concussion2025
SNTF is a blood biomarker for the diagnosis and prognosis of sports-related conc2024
SNTF is a blood biomarker for the diagnosis and prognosis of sports-related conc2018
Methods for detecting cell apoptosis2007
Recombinant enzymatically active calpain expressed in a baculovirus system2000
Methods for detecting cell apoptosis2000
Multicatalytic protease inhibitors1999
Methods for detecting calpain activation and identifying calpain inhibitors1999
Recombinant enzymatically active calpain expressed in a baculovirus system1999
Multicatalytic protease inhibitors1998
Gene-targeted mice with humanized A.beta. sequence and Swedish FAD mutation1998
Multicatalytic protease inhibitors1997